Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/60803
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hiwase, Devendra | en |
dc.contributor.author | White, Deborah Lee | en |
dc.contributor.author | Saunders, Verity Ann | en |
dc.contributor.author | Kumar, Shaji | en |
dc.contributor.author | Melo, Junia V. | en |
dc.contributor.author | Hughes, Timothy Peter | en |
dc.date.issued | 2009 | en |
dc.identifier.citation | Leukemia, 2009; 23(6):1205-1206 | en |
dc.identifier.issn | 0887-6924 | en |
dc.identifier.uri | http://hdl.handle.net/2440/60803 | - |
dc.description.statementofresponsibility | D.K. Hiwase, D.L. White, V.A. Saunders, S. Kumar, J.V. Melo and T.P. Hughes | en |
dc.language.iso | en | en |
dc.publisher | Nature Publishing Group | en |
dc.rights | Copyright status unknown | en |
dc.title | Short-term intense Bcr–Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL⁺ cells | en |
dc.title.alternative | Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cells | en |
dc.type | Journal article | en |
dc.contributor.school | Health Sciences Faculty Office | en |
dc.identifier.doi | 10.1038/leu.2009.45 | en |
Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.